Added: Aug 25, 2008
JAMA Report: Dr Steven Nissen, a cardiologist at the Cleveland Clinic, presents a study reported in JAMA that a new wieght loss drug may help patients with coronary artery disease. The drug, Rimonabant, is used in Europe, but not yet approved in the United States for weight loss. Although further studies are necessary, this study did show some benefit in patients with heart disease.
Join VideoMD for a free account, or Login if you are already a member.